In an effort to support global initiatives to contain the spread of the new coronavirus (COVID-19), the Academy is presenting Spring 2020 events through online platforms and some of our previously scheduled events are being postponed to a later date. Please check our events listing for the latest information and contact our Customer Service team with any additional questions. For Academy programs and resources about COVID-19, click here.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.


Circulating Nucleic Acids in Plasma or Serum

Edited by Edited by Philippe Anker and Maurice Stroun (Pavillon des Isotopes, University of Geneva, Switzerland)
Circulating Nucleic Acids in Plasma or Serum

Published: April 2000

Volume 906

Learn More

Free DNA present in both healthy and diseased human plasma has been found to express specific point mutations that may serve as diagnostic signposts - perhaps to reliable, noninvasive tests for breast and lung cancer, hematopoietic malignancies, colorectal or pancreatic carcinoma, and other tumors. In another research area, fetal DNA has been detected in maternal serum which presents an early-horizon alternative in utero test for gender. A parallel discovery of rearranged immunoglobulin heavy -chain DNA in the plasma of patients with Hodgkin's disease or acute B cell leukemia has also emerged. These fast-emerging indicators suggest that it is time to standardize research techniques and develop protocols that can take a measure of circulating DNA's impact as a new diagnostic tool.

This volume is out of print.